MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

North AmericanPharmaceutical Segment$86,773M Oncology AndMultispecialty Segment$14,222M Medical SurgicalSolutions Segment$2,819M (4.37%↑ Y/Y)Prescription TechnologySolutions Segment$1,566M (9.21%↑ Y/Y)Revenues$105,380M (7.72%↑ Y/Y)Gross profit$3,685M (12.38%↑ Y/Y)Cost of sales$101,695M (7.56%↑ Y/Y)Operating income$1,319M (27.32%↑ Y/Y)Other income, net$66M (3.13%↑ Y/Y)Total operatingexpenses$2,366M (5.48%↑ Y/Y)Claims and litigationcharges, net$34M Income before incometaxes$1,308M (24.45%↑ Y/Y)Interest expense$77M (57.14%↑ Y/Y)Selling, distribution,general, and...$2,264M (3.10%↑ Y/Y)Restructuring, impairment, andrelated charges, net$136M (189.36%↑ Y/Y)Net income$1,032M (24.19%↑ Y/Y)Income tax expense$276M (25.45%↑ Y/Y)Net incomeattributable to mckesson...$614M (-21.68%↓ Y/Y)Net incomeattributable to...$418M (789.36%↑ Y/Y)
Income Statement
mck_logo_blue-svg

MCKESSON CORP (MCK)

mck_logo_blue-svg

MCKESSON CORP (MCK)

source: myfinsight.com